CD4 and hepatitis A virus infection: In the multivariable analysis, seroreversion at month 60 was associated with a higher BMI, lowest-ever CD4 cell count, VL <200 copies/mL at vaccination, and receipt of hepatitis A vaccine, inactivated (Merck) as first dose of HAV vaccine. Seroprotection remained >90% among participants who underwent vaccination while on ART.